Dual-Contrast MRI for Liver Lesion Characterization | Podcast

Welcome to the RSNA RadioGraphics Podcast.My name is Sudeep Soni, and I am a body radiologist for the Community Radiology Division of Johns Hopkins.Today, we're discussing an important evolution in liver MRI, dual contrast agent imaging for focal liver lesion characterization, based on a 2026 RadioGraphics article by Dr. Anup Shetty from the Malacar Institute of Radiology and colleagues.Focal liver lesions are incredibly common, present in at least 15% of the population, and while many are benign, diagnostic uncertainty can lead to repeat imaging, unnecessary biopsies, increased cost, and significant patient anxiety.Traditionally, radiologists choose either an extracellular agent or a hepatobiliary agent, each with its distinct strengths and equally important distinct limitations.The central message of today's article is simple but powerful.Using the wrong contrast agent at the initial MRI can compromise diagnostic accuracy.The authors propose a solution, a sequential dual contrast agent MRI protocol that combines the advantages of both agents in a single examination.Over the next 15 minutes, we will review why this matters, how the protocol works, and when it meaningfully changes patient care.Let's start by discussing why contrast choice matters.Dynamic contrast enhancement is one of the most critical components of liver MRI interpretation.The enhancement pattern, and particularly during arterial, porovenous, delayed, and hepatobiliary phases, often determines whether lesions can be confidently classified as benign or malignant.However, not all gadolinium-based contrast agents behave the same way.Broadly, liver MRI contrast agents fall into three categories.First, extracellular agents, or ECAs.Second, hepatobiliary agents, or HBAs.Most commonly, gadoxitate.And third, hybrid agents, such as gadobenate.Each of these agents interrogates a diYerent aspect of lesion biology.ECAs highlight vascular behavior.HBAs provide functional information about hepatocyte uptake.Hybrid agents attempt to combine both, but with important tradeoYs.